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ABSTRACT In humans, a primate-specific variable-
number tandem-repeat (VNTR) polymorphism (4 or 5
repeats 54 nt in length) in the circadian gene PER3 is
associated with differences in sleep timing and homeo-
static responses to sleep loss. We investigated the
effects of this polymorphism on circadian rhythmicity
and sleep homeostasis by introducing the polymor-
phism into mice and assessing circadian and sleep
parameters at baseline and during and after 12 h of
sleep deprivation (SD). Microarray analysis was used to
measure hypothalamic and cortical gene expression.
Circadian behavior and sleep were normal at baseline.
The response to SD of 2 electrophysiological markers
of sleep homeostasis, electroencephalography (EEG) 
power during wakefulness and  power during sleep,
were greater in the Per35/5 mice. During recovery, the
Per35/5 mice fully compensated for the SD-induced
deficit in  power, but the Per34/4 and wild-type mice
did not. Sleep homeostasis-related transcripts (e.g.,
Homer1, Ptgs2, and Kcna2) were differentially expressed
between the humanized mice, but circadian clock genes
were not. These data are in accordance with the hypoth-
esis derived from human data that the PER3 VNTR
polymorphism modifies the sleep homeostatic re-
sponse without significantly influencing circadian pa-
rameters.—Hasan, S., van der Veen, D. R., Winsky-
Sommerer, R., Hogben, A., Laing, E. E., Koentgen, F.,
Dijk, D.-J., Archer, S. N. A human sleep homeostasis
phenotype in mice expressing a primate-specific PER3
variable-number tandem-repeat coding-region polymor-
phism. FASEB J. 28, 000–000 (2014). www.fasebj.org
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There are individual differences in sleep timing
and duration and responses to sleep loss, but the
underlying mechanisms remain poorly understood (1,
2). Sleep-wake cycles are determined by the interaction
of circadian timing and sleep homeostasis (3, 4), and
some of the molecular mechanisms of both processes
have been identified.
Cellular circadian rhythms are generated by a tran-
scriptional–translational feedback oscillator consisting
of the positive regulators CLOCK and BMAL1 and the
negative regulators Period (PER) and Cryptochrome
(CRY), which inhibit expression (5). Alterations in
these genes are associated with the timing of sleep-
wake activity and sleep homeostasis (6). In particular,
during non-rapid eye movement sleep (NREMS), elec-
troencephalography (EEG)-measured  power, an es-
tablished marker of sleep homeostasis, is affected by
clock genes (7, 8). Sleep duration is associated with
single-nucleotide polymorphisms (SNPs) in CLOCK
(9), and sleep-timing preference and delayed sleep-
phase disorder (DSPD) are associated with polymor-
phisms within PER2, PER3, and CLOCK, although the
results have not always been replicated (2). Most hu-
man association studies have not shown whether poly-
morphisms affect the circadian or homeostatic aspect
of sleep regulation, and many show no direct link
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between specific polymorphisms and causative mecha-
nisms (2).
Although Per3 was originally described as a clock
gene and data show that it interacts with other clock
elements (10), its redundant role within the circadian
clock is far from clear (11, 12). Functional knockout
(KO) of PER3 in mice has a minimal effect on the
central circadian clock (11–14), but it alters sleep
homeostasis (15). A primate-specific variable-number
tandem-repeat (VNTR) polymorphism (54 bp, re-
peated 4 or 5 times) in human PER3 associates with
diurnal preference (16–19), DSPD (16, 17), sleep–
wake timing (19), sleep homeostasis (20, 21), and
cognitive vulnerability to sleep loss (20, 22–24). The
PER3 VNTR is not associated with major changes in
either circadian phase (20, 25, 26) or circadian period,
assessed in vivo or in vitro (27). We therefore hypothe-
sized that the PER3 VNTR affects sleep homeostasis,
rather than circadian rhythmicity (28).
In this study, we sought to investigate whether the
above-mentioned associations between the PER3 VNTR
polymorphism and human sleep phenotypes reflect a
direct causative effect of the polymorphism on homeo-
static, but not on circadian, sleep regulation. We cre-
ated 2 separate transgenic mouse lines expressing the
human 4- and 5-repeat of the PER3 VNTR and assessed
behavioral circadian rhythmicity and EEG-assessed as-
pects of sleep homeostasis. Sleep deprivation (SD) is
known to affect cortical clock gene expression in ro-
dents (29), and the hypothalamus contains both the
circadian clock in the suprachiasmatic nuclei (SCNs)
and the ventrolateral preoptic (VLPO) nucleus, which
regulate sleep–wakefulness (30). We therefore assessed
the effects of the VNTR on sleep-associated gene ex-
pression in the cortex and hypothalamus in these
humanized mice.
MATERIALS AND METHODS
Generation of C57BL/6 transgenic mice
Targeting vectors were created by PCR from C57BL/6
genomic DNA using the plasmid FLSniper as the vector
backbone (Ozgene Pty. Ltd., Bentley, WA, Australia). Tar-
geting vectors were designed to conditionally replace
mouse exon 18 with human exon 18, coding for either the
4- or 5-repeat VNTR (Fig. 1A). The targeting construct
contained a cDNA sequence of wild-type (WT) mouse
exons 18 –21, with a downstream phosphoglycerine kinase
(PGK) promoter driving a neomycin (Neo) selection
marker. The sequence was flanked by locus of X over P1
(LoxP) excision sites and followed by the human PER3
exon 18, containing either the 4- or 5-repeat allele of the
VNTR. For the known SNP T3110C within the VNTR (31),
we chose to express the more common allele. Gene target-
ing was performed in the embryonic stem (ES) cell line
Bruce4, which was derived from a C57BL/6-Thy1.1 con-
genic strain (32). Chimeras were crossed to C57BL/6J. The
genetic background of the resulting mice is C57BL/6, with
minor polymorphic contributions from the ES cells (33).
The vector was introduced into the ES cells by electropo-
ration, and successful homologous recombination was con-
firmed by screening for the antibiotic-resistant ES cells.
After confirmation of integration of the targeting vector by
Southern blot, positive ES cells were expanded and in-
jected into blastocysts, which were then implanted in
pseudopregnant females (C57BL/6), and chimeras were
bred to obtain germline transmission.
ES-derived coat-color offspring were genotyped with
Southern blot analysis and used as founders for the breed-
ing colony. These conditional (Per3/) mice expressed a
WT protein coded by the WT gene (exons 1–17) and
transgenic cDNA WT sequence (exons 18 –21; see Fig. 1B).
Design and construction of the targeting vectors and
creation of transgenic offspring were performed by Oz-
gene.
By applying tyrosine recombinase/locus of X (Cre-Lox)
recombination, humanized knock-in (KI) and WT mice were
created by crossing homozygous C57BL/6 transgenic mice
with mice on the same background that expressed Cre ubiq-
uitously under the control of the PGK promotor at the
ROSA26 locus (Ozgene). The F1 offspring of this cross were
heterozygous for both Cre and the humanized Per3 construct.
These offspring were used in selective breeding to create
mice homozygous for the KI construct and not expressing Cre
[Per3 homozygous for the 4-repeat or 5-repeat allele (Per34/4
and Per35/5, respectively) mice] and mice homozygous for the
WT mouse Per3 gene and not expressing Cre. These mice were
used to establish the lines used in the experiments. Note that
the KI and WT mice were derived from the same conditional
transgenic mice after selective crossing with the Cre mice and
were genetically identical, except for the presence or absence
of the VNTR.
Figure 1. A) Schematic representation of the hu-
manized Per3 targeted alleles. A cDNA insert con-
taining mouse exons 18–21 was inserted between 2
LoxP excision sites in mouse intron 17, replacing
exon 18. After the second LoxP excision site, the
human exon 18 (coding for either the 4- or 5-repeat
VNTR allele) replaced mouse exon 18, followed by
mouse intron 18 and the subsequent WT mouse
homology arm sequence. B) Top: transgenic indi-
viduals express mRNA containing WT mouse exons
1–17, followed by the cDNA-coded WT exons 18–
21. Bottom: after Cre-Lox recombination, human-
ized mice also express WT mouse exons 1–17, now
followed by human exon 18 and WT mouse exons
19–21. C) Representative PCR products for geno-
typing of WT, Per3/, and humanized mice.
Per3KI/KI, humanized KI; X, negative control.
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Two PCR primer sets were used for genotyping. Set 1 was
d i r e c t e d a t t h e homology arms (forward : 5 = -
AGCCGGGGTCAGAGCACAGTAGTT-3=; reverse: 5= -
ATCCATGAGCCCAAGCAAATCCT-3=), and set 2 was directed
at PGK-NEO inserts (forward: 5=-GTCTGCCGCGCTGTTCTC-
CTCTTC-3=; reverse: 5=-CTTCGCCCAATAGCAGCCAGTCC-
3=). The combination of these primers resulted in PCR products
of 583 bp (set 1) in WT mice, 418 bp (set 2) in conditional
Per3/ mice, and 886 bp (set 1) in Per34/4 and Per35/5 mice
(Fig. 1C). Primer set 2 was also used to identify Cre-expressing
mice, with a PCR product of 354 bp. Direct sequencing of Per3
transcript copy DNA showed that these mice expressed the
expected KI constructs.
Housing conditions
Humanized Per34/4 and Per35/5 mice and their WT controls
were bred in-house from homozygous breeding pairs. During
experimentation, the mice were individually housed in light-
tight, sound-attenuated cabinets, with food and water pro-
vided ad libitum. The mice were maintained on a 12-h
light-dark (LD) cycle, with a light intensity of 800  13.4
mW/m2 at the level of the cage bottom during the light
period, and were kept at a controlled ambient temperature
(20–22°C) and relative humidity (5510%). Nesting material
(bedding) was provided to aid thermoregulation. All experi-
mental procedures received a favorable opinion by the Uni-
versity of Surrey Animal Ethics Committee and were carried
out under a U.K. Home Office License and in accordance
with the Declaration of Helsinki.
Circadian period protocol
WT and transgenic C57BL/6 mice (n16/genotype, 7 fe-
males and 9 males; age 64  2 d; meansem) were individ-
ually housed with a 12-h LD cycle. After 14 d, the mice were
exposed to four 14-d episodes of constant light of increasing
intensity (0, 33, 171, and 865 mW/m2) and a final 14-d
episode of constant darkness. The blue-enriched LED light
spectrum did not vary between intensities. Running-wheel
activity (1 min resolution) was recorded throughout the
experiment (ClockLab; Actimetrics, Wilmette, IL, USA). Dur-
ing the last 10 d for each light condition, the length of the
free-running circadian behavioral period was calculated by
periodogram analysis (34). Free-running periods were com-
pared by using PROC MIXED in SAS 9.2 (SAS Institute, Cary,
NC, USA) with the factors genotype, sex, and light intensity.
Representative activity profiles were double plotted for each
genotype as qualitative actograms, and free-running periods
are indicated as group means  sem.
Duration and temporal pattern of EEG-assessed vigilance
states (VSs)
A telemetric transmitter (volume, 1.9 cm3; total weight, 3.4 g;
TL11M2-F20-EET; DSI, St. Paul, MN, USA) connected to
electrodes for continuous EEG and electromyography (EMG)
recordings was implanted in 8 adult male C57BL/6 mice per
genotype (Per34/4, Per35/5, and WT; N24, 78.70.7 d old;
meansem). Body weights were not similar between the
genotypes [WT, 29.01.3 g; Per34/4, 26.51.8 g; Per35/5,
29.52.0 g (avg.sd); P0.005; PROC MIXED]. The Per34/4
mice weighed less than the WT (P0.05) and Per35/5 mice
(P0.01; LSMEANS after Tukey adjustment). In mice under
anesthesia (isoflurane induction 3.6%, maintenance 1–2%),
2 stainless-steel EEG electrodes (length of screw shaft, 2.4
mm; outer diameter of screw thread, 1.19 mm) were im-
planted epidurally over the right frontal and parietal cortices
(35) and connected to the telemetry transmitter via medical-
grade stainless-steel wires (surrounded by silicone tubing).
Figure 2. Circadian period in constant dark and constant light. A) Examples of individual activity records (per 24 h, double
plotted) for WT, Per34/4, and Per35/5 mice. Activity is represented by black bars. Successive light conditions (white, light; gray,
continuous light or dark) over the 84-d period are indicated at right. Mice were first entrained to a 12-h LD cycle and then were
exposed to a period of constant darkness (DD), followed by 3 successive conditions of increasing levels of constant light, before
returning again to DD (arrows). B) For each light condition, the circadian free-running period was calculated from
periodogram analysis over the last 10 d of that condition and is shown as average  sem per genotype per light condition.
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The EEG electrodes and connections to the subcutaneous
wiring were covered with dental cement (GC Fuji Plus; GC
United Kingdom Ltd., Newport Pagnell, UK). Two EMG
stainless-steel leads were inserted into the neck muscle 5
mm apart and sutured in place. The telemetry transmitter was
placed in a subcutaneous pocket and positioned along the left
dorsal flank of the mouse. Analgesia was administered by
subcutaneous injection at the onset of surgery (Vetergesic, 30
g/kg). After surgery, the animals were allowed to recover for
11  1 d (meansd), and baseline (BSL) data collection was
begun when the mice were 89.6 0.8 wk of age (meansem).
The telemetric transmitters were activated 2 d before the
BSL day, and EEG/EMG signals were then recorded contin-
uously for 72 h (Dataquest ART; DSI). The EEG and EMG
signals were modulated with a high-pass (3 dB, 1.0 Hz) and a
low-pass antialiasing (48 Hz) analog filter. The data analyzed
consisted of continuous 72-h recordings, including a 24-h
BSL period starting at light onset [zeitgeber time (ZT) 0],
followed by a 12-h period of SD in light (SD-L) and a
subsequent 36-h period of sleep recovery (Rec).
SD was carried out starting at light onset (ZT 0) for 12
consecutive hours, by the simultaneous presence of at least 2
(ZT 0–9) or 3 researchers (ZT 9–12) for each group of 8 mice
(of mixed genotypes). SD was performed by sequential intro-
duction of different novel objects into the cage when the
animal appeared to become drowsy (up to 14 in total,
consisting of nesting material, blue tissue, open or closed
cardboard rolls of different sizes, pieces of wood, chemiwood
prisms, plastic tubes of different sizes, tube lids, and Petri
dishes). If necessary, additional arousal was achieved by
disturbing the bedding and/or the nest. The cages were
exchanged twice (at ZT 6 and 9) for fresh ones, to provide
additional stimulation. Researchers were blinded to genotype
during SD, and the objects were introduced into the cages in
the same order.
The telemetric EEG and EMG data were transmitted at 455
kHz to an RPC-1 receiver (DSI) and sampled at 250 Hz. VSs
for consecutive 4 s epochs were classified by visual inspection
of the EEG and EMG signals, according to standard criteria
(35), as follows: wakefulness (high and variable EMG activity
and a low-amplitude EEG signal); NREMS (high EEG ampli-
tude, dominated by slow waves and low EMG); and rapid eye
movement sleep (REMS; low EEG amplitude,  oscillations of
5–9 Hz, and loss of EMG muscle tone).
The time spent in each VS was expressed as a percentage of
total recording time over 2 time intervals (i.e., 2 or 12 h).
REMS was also expressed as a percentage of total sleep time
(TST). The effects of SD on Rec NREMS and REMS were
assessed as accumulated differences from the BSL condition
for consecutive 1-h intervals starting at light onset (ZT 0).
EEG power density
EEG power spectra were computed for consecutive 4-s epochs
by a fast Fourier transform (FFT; frequency range, 0.98–
47.85 Hz; resolution, 0.244 Hz; Hanning window function).
Only artifact-free epochs (97%) were included in the EEG
spectral analyses. EEG power spectra were determined for
NREMS, REMS, and wakefulness during the 12-h BSL light
(BSL-L) period. EEG power spectra are expressed as a
percentage of total EEG power (frequency range: 0.98 –
47.85 Hz; resolution: 0.24 Hz; graphed frequency range:
0.98 –31.98 Hz).
The changes in the waking EEG spectra during 12 h SD
were determined by expressing EEG spectra individually as a
percentage of the wakefulness spectra in the 12-h BSL-L
period (range: 0.98–47.85 Hz; resolution: 0.24 Hz). The time
course of EEG spectra changes during forced wakefulness in
SD was assessed by dividing this period into 36 time intervals,
in each of which an equal number of 4-s awakening epochs
were contributed by the individual mice. The  peak fre-
quency (TPF) in REMS was determined by recording the
frequency at which EEG power density was at its maximum.
To further quantify the changes in the awake EEG spectra,
the following frequency ranges were defined: upper , 8.5–11
Hz; 	-2, 20–35 Hz; and 
-1, 35–48 Hz. Mean EEG power in
these frequency bands was expressed as a percentage of the
mean EEG power reached in that specific band during
wakefulness in the BSL-L period.
TABLE 1. VSs and  power during 12 h NREMS
Parameter BSL-L BSL-D sd-L Rec-D1 P vs.BSL-D Rec-L P vs. BSL-L Rec-D2 P vs.BSL-D
Awake (%)
WT 38.2  1.2 77.9  2.4 98.88  0.09 58.0  4.2 0.0001 40.7  1.3 0.05 73.3  3.0 0.01
Per35/5 38.7  1.1 77.0  1.6 99.20  0.09 57.6  1.5 0.0001 41.2  1.4 0.05 71.6  1.2 0.001
Per35/5 40.9  1.6 76.3  1.8 99.16  0.09 53.4  1.8 0.0001 42.3  1.8 68.5  1.8 0.0001
NREMS (%)
WT 46.8  1.6 19.3  2.1 1.13  0.26 32.7  3.3 0.0001 44.5  1.7 22.9  2.6 0.05
Per35/5 46.1  1.4 20.1  1.5 0.80  0.09 32.3  1.7 0.0001 42.1  1.9 0.05 23.9  1.3 0.01
Per35/5 44.6  1.2 20.6  1.6 0.84  0.09 36.4  1.8 0.0001 41.9  1.5 26.4  1.6 0.001
REMS (%)
WT 15.0  1.1 2.8  0.4 0.00  0.00 9.4  1.2 0.0001 14.8  1.2 3.9  0.5
Per35/5 15.2  0.9 2.8  0.2 0.00  0.00 10.1  0.8 0.0001 16.8  1.4 4.6  0.3 0.001
Per35/5 14.4  1.2 3.1  0.3 0.00  0.00 10.2  0.8 0.0001 15.8  1.6 5.1  0.4 0.0001
REMS/TST (%)
WT 24.3  1.8 12.3  1.1 NA 21.9  1.3 0.0001 25.0  2.1 14.4  1.2
Per35/5 24.9  1.5 12.4  0.6 NA 24.0  2.3 0.0001 28.6  2.3 0.05 16.3  1.3 0.05
Per35/5 24.3  1.6 12.8  0.8 NA 22.0  1.7 0.0001 27.2  2.4 16.2  0.9 0.05
 power (%)
WT 100 (ref.) 142.6  5.8 [304.7  15.0] 136.8  8.0 97.3  4.0 152.1  9.3
Per35/5 100 (ref.) 148.8  5.0 [328.1  10.2] 136.4  5.8 95.4  4.5 145.4  8.7
Per35/5 100 (ref.) 146.1  7.6 [364.0  20.9] 155.6  9.6 110.6  7.2 165.1  10.9
Values represent mean  se percentage of time awake, NREMS, and REMS (percentage of total recording time), REMS/TST (percentage
TST) and  power (percentage of BSL-L ) calculated per 12-h period. P  0.05, P  0.01, P  0.001, and P  0.0001 represent increase or
decrease compared to corresponding BSL (PROC MIXED followed by LSMEANS). NA, not applicable.
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EEG  power during NREMS was computed by averaging
the EEG power in the frequencies ranging from 0.98 to 3.91
Hz. Mean values were calculated by dividing the 12-h periods
into 12 (BSL-L); 5 [BSL-dark (BSL-D)]; 9 [12-h period
following SD: first Rec dark (Rec-D1)]; 11 [Rec light (Rec-
L)]; or 6 [second Rec dark (Rec-D2)] intervals to which an
equal number of NREMS epochs contributed within each
mouse. Mean values were also individually normalized to the
mean  power in NREMS in the last 4 h of the BSL-L period
(i.e., the lowest mean level reached during BSL). The  power
rebound during the first interval after SD was calculated as a
percentage of  power within the interval immediately pre-
ceding SD. Accumulated differences (from the BSL condi-
tion) of  power during NREMS are represented as hourly
values of  energy (i.e., summed  power over all epochs) and
expressed as a percentage of the total  energy during the 24
h of the BSL day.
Statistics for sleep analyses
Data were analyzed with SAS v9.2 (SAS Institute). For the EEG
power spectra (per VS during BSL-L), the spectral changes in
the awake EEG (during SD-L), and the time courses of
accumulated differences in NREMS, REMS, and slow-wave
energy (SWE) during SD and the 36-h Rec period after SD,
nonparametric analyses were used with PROC NPAR1WAY
(Kruskal-Wallis test), followed by the Student-Newman-Keuls
(SNK) post hoc analysis. The TPF data between the genotypes
were compared by using PROC TTEST. PROC MIXED was
also used to compute intraclass correlation coefficients
(ICCs). ICCs were computed with their 95% confidence
intervals (CIs). In our study, the ICC indicates the ratio of the
between-genotypes (Per34/4 and Per35/5 only) variance to the
total variance (within-genotype variance  between-genotypes
variance). ICCs can have any value between 0 and 1; higher
values are indicative of stability of observations within a genotype
(or genotype effect). At BSL, VS data (per 2 and 12 h), and time
courses of , upper-, 	-1, and 
-1 power were analyzed by using
PROC MIXED for analysis of variance (ANOVA; factor genotype
and interaction genotype  time; additionally, factor SD and
interaction SD  time for VS per 12 h only), followed by
LSMEANS post hoc multiple pair-wise comparisons. PROC
MIXED was also used to assess genotype effects on the immedi-
ate  power rebound (using the log10 values).
Microarray gene expression analysis
To investigate the effects of the insertion of the VNTR
transgene on gene expression in the hypothalamus and
cortex of the Per3 KI mice, we used the same 12-h SD
protocol. After 14 d of entrainment to a 12-h LD cycle, SD was
carried out as described for the sleep EEG experiment for
each group of 8 mice [of mixed genotypes; n8/genotype
(Per34/4, Per35/5 and WT); age 102  2.4 d; meansem]. At
the end of the SD period, whole brains were collected under
red light and stored immediately at 80°C in RNAlater
(Qiagen, Hilden, Germany) until RNA extraction from the
hypothalamus and cortex tissue with the RNeasy kit (Qiagen).
Total RNA (200 ng) was used to synthesize the labeled cRNA
(Quick Amp; Qiagen), which was hybridized to Whole-Mouse
Genome 444K slides (design ID 014868; Agilent Technolo-
gies, Santa Clara, CA, USA). Array features were extracted
with Agilent Feature Extraction software.
We also measured hypothalamic gene expression in a
protocol where behavioral activity is suppressed by light (13).
After 10 d in the 12-h LD cycle, mice (male C57BL/6 mice:
n 8/genotype; age 75 3 d, meansem) received 17 cycles
of 3.5 h light (1702.3 mW/m2):3.5 h dark, starting at
original light onset. Brains were collected in the 17th light
cycle (where the largest behavioral difference between WT
and Per3 KO mice had been observed; ref. 13) and stored at
80°C in RNAlater (Qiagen). RNA extracted from the hypo-
thalamus microarrays was hybridized with labeled cRNA as
described above. Samples of 1 Per35/5 and 1 WT mouse were
excluded from further analyses because of the poor quality of
the arrays, based on the output of the Agilent feature extraction.
Expression levels were analyzed with GeneSpring 12 (Agi-
lent). The samples were normalized by percentile shift to the
75th percentile. The probes were classified as differentially
expressed with avalue of   0.05 in a 1-way ANOVA and
unpaired t test (asymptotic P value computation with
Benjamini-Hochberg correction for multiple testing) and/or
Figure 3. EEG spectral profiles of NREMS, REMS, and
wakefulness during the BSL-L period in WT, Per34/4, and
Per35/5 mice. Means (n8/genotype) of the EEG spectra
were normalized to total EEG power for all frequencies within
corresponding sleep states. Genotype effects are indicated as
follows: inverted black triangle, Per34/4 lower than both WT
and Per35/5; gray triangle, Per35/5 higher than Per34/4; in-
verted gray triangle, Per35/5 lower than both WT and Per34/4.
All P  0.05 (PROC NPAR1WAY followed by SNK post hoc).
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a probability of false prediction (PFP)  0.015 in a rank
product analysis (36).
Gene Ontology (GO) analysis of the differentially ex-
pressed probes was conducted in WebGestalt (37) using the
mouse 444K (ver. 1; Agilent) as the background distribu-
tion. All microarray data have been deposited in the U.S.
National Center for Biotechnology Information (Bethesda,
MD, USA) Gene Expression Omnibus (GEO) database (GEO
accession number GSE55255; http://www.ncbi.nlm.nih.gov/
geo/).
RESULTS
Circadian period in constant dark and constant light
Representative examples of individual records of behav-
ioral activity for each genotype are shown in Fig. 2A.
During the 12-h LD cycle, behavioral rest-activity cycles
were entrained to the 24-h period in all genotypes.
Free-running behavioral activity rhythms were observed
in all constant-light and constant-dark conditions. As
expected (38), the free-running circadian period
lengthened with increasing light intensities (main ef-
fect of light, P0.0001), and no significant main effect
of genotype or interaction between genotype and light
was observed (all genotype and lightgenotype, P
0.05; Fig. 2B). The females exhibited a larger increase
in period length than did the males in response to the
dimmest and brightest light conditions (lightsex,
P0.005, LSMEANS contrast P0.0005 and 0.0001 for
33 and 865 mW/m2, respectively). This sex difference
was observed in all mice and was not affected by
genotype (lightsexgenotype, P  0.05).
VSs and EEG power spectra at BSL
During the BSL day, the 12-h averages of time spent in
wakefulness or in NREMS or REMS were similar in the
Per34/4, Per35/5, and WT mice (Table 1).
The EEG power spectra (in each VS) during the 12-h
BSL-L period in the WT, Per34/4, and Per35/5 mice
differed only in narrow frequency ranges (PROC
Figure 4. Time course of EEG spectral profiles during the 12-h SD period. Left panel: mean EEG spectra within 36 time intervals
were expressed as a percentage of the mean spectral profile for awake EEG in the BSL-L period for each genotype separately.
Changes from BSL are plotted as a heat map (key at right): dark blue values represent reduced EEG power compared to BSL;
light blue values are similar to BSL (100%); warm colors (green to red) represent increased EEG power compared to BSL.
Statistics panel indicates overall genotype effects (PROC NPAR1WAY, P0.05) over time in the full frequency range; symbols
(key at right) represent significant genotype effects. Right panels: means  sem (n8/genotype) of EEG power in the upper-
(bottom panel), 	-2 (middle panel), and 
-1 (top panel) ranges were calculated hourly and expressed as a percentage of the
mean EEG power in that range during spontaneous wakefulness in the BSL-L period. Hourly intervals with significant genotype
effect. Black symbols indicate significant differences between Per35/5 and Per34/4; gray symbols indicate significant differences
in the 	-1 range between Per35/5 and WT (PROC MIXED followed by LSMEANS post hoc). *P  0.05, #P  0.01, $P  0.001.
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NPAR1WAY, P0.05; Fig. 3). During NREMS, the
Per34/4 mice had lower power in 21.97–22.22 Hz than
the Per35/5 and WT mice (SNK, P0.05). During
REMS, the Per35/5 mice showed lower power at 6.59 Hz
than the WT and Per34/4 mice (SNK, P0.05), as well as
higher power at 21.73 Hz compared to the Per34/4 mice
(SNK, P0.05). In addition, the Per34/4 mice had
decreased power at 7.81 and 8.30 Hz compared to the
WT and Per35/5 mice (SNK, P0.05).
To confirm the genotype effect in the  range of the
REM spectrum, we computed the ICCs for each fre-
quency bin by calculating the ratio of the between-
genotype variance (Per34/4 and Per35/5 only) to the total
variance (within-genotype variance  between-geno-
types variance). In accordance with the observed geno-
type effect, the highest ICC (0.48) was obtained for the
8.30-Hz bin, indicating stability of power density in the
upper- range within the genotypes.
Behavior and EEG-assessed wakefulness during SD
To evaluate and compare the effects of SD on awake
EEG in the WT, Per34/4, and Per35/5 genotypes, EEG
spectra were computed over a frequency range of 1 to
48 Hz during the 12 h of SD. In all genotypes, the
forced wakefulness during SD was characterized by an
immediate and lasting increase (1.4- to 2.4-fold) in the
upper--range activity (8.5–11 Hz range), compared to
BSL wakefulness during light (power heat map in Fig. 4).
This -range increase was more pronounced in the
Per35/5 and WT (with an increase up to 2.4-fold) than in
the Per34/4 mice. Frequencies above  (11 Hz) also
showed genotype effects (Fig. 4, statistics panel).
To further characterize the effects of SD on awake
EEG, we calculated the EEG power per hour in the
upper- (8.5–11 Hz), 	-2 (20–35 Hz), and 
-1 (35–48
Hz) frequency bands. In the upper- range, the Per35/5
mice showed a significantly higher power during 5–6 h
after SD onset compared to Per34/4 mice (PROC
MIXED P0.05, LSMEANS P0.05). Similarly, in the
	-2 and 
-1 range, Per35/5 mice showed increased
power (compared to Per34/4 mice) during the middle
of the SD period (PROC MIXED P0.05; for post hoc
details, see Fig. 4, right panels).
Rec sleep after SD
During the Rec-D1 period after the 12 h SD, we
observed a reduced time spent awake and an increased
time spent in NREMS and REMS in all 3 genotypes,
compared to that in the BSL-D period (Table 1).
Compared to the BSL-L period, wakefulness increased
in the WT and Per34/4 mice during the 12 h Rec-L
period. The Per34/4 mice showed an increase in REMS
and TST and a decrease in NREMS during the Rec
period, compared to BSL (Table 1). During the 12 h
Rec-D2 period, wakefulness remained significantly re-
duced in all 3 genotypes (compared to BSL-D). NREMS
remained increased in all 3 genotypes, and NREMS
Figure 5. Hourly time course of accumulated differences in REMS time, NREMS time, and SWE between BSL conditions during
SD and the 36 h Rec period after SD. Accumulated values (means sem; n8/genotype) are expressed relative to BSL
conditions (black horizontal dashed line) for each genotype (gray triangle, WT; black circle, Per34/4; white square, Per35/5).
Genotype effects are indicated for the hourly intervals for the comparison of SWE accumulation between the 3 genotypes: black
symbols indicate significance for Per35/5 higher than Per34/4; gray symbols for Per35/5 higher than WT; white symbols for Per35/5
higher than both Per34/4 and WT (PROC NPAR1WAY per interval followed by SNK post hoc). *P  0.05, #P  0.01.
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remained increased in the 2 KI genotypes only, com-
pared to the BSL-D period (Table 1).
To further characterize the effects of SD, we com-
puted the accumulated hourly differences in REMS and
NREMS and SWE ( power in NREMS) between the
mean BSL and SD values and the subsequent 36 h Rec
period (Fig. 5). Negative slopes indicate a loss, null
slopes indicate no loss or gain, and positive slopes
indicate a gain in sleep time or sleep intensity, relative
to BSL. Because each interval is an accumulation of all
preceding intervals, statistical analyses were performed
only on data from the last 1-h interval. No genotype
differences were found in REMS and NREMS times. By
contrast, a genotype effect was found for SWE (PROC
NPAR1WAY, P0.05), where the Per35/5 mice showed a
significantly higher SWE accumulation than the Per34/4
and WT mice from h 3 of sleep Rec (SNK, P0.05 and
P0.01; Fig. 5). In addition, only the Per35/5 mice fully
compensated for the level of sleep deficit by returning to
BSL, whereas, in the Per34/4 and WT mice, accumulated
levels remained significantly lower than BSL (paired t
tests: Per34/4, P0.005; WT, P0.05; Fig. 5).
Figure 6. Time courses of EEG  power, TST, NREMS, and REMS across the entire 72-h period. Top panels: time distribution
of EEG  power during NREMS. EEG  power (means sem; n8/genotype) is expressed relative to the last 4 h of the BSL-L
period. There was an overall effect of genotype (PROC MIXED LSMEANS, P0.05), and specific contrasts were observed
between the 3 genotypes. Black symbols indicate Per35/5 higher than Per34/4; gray symbols, Per35/5 higher than WT; white
symbols, Per35/5 higher than both Per34/4 and WT. *P  0.05, #P  0.005, and $P  0.0005. Bottom panels: time course of 2-h
binned values (meanssem) of total sleep, NREMS, and REMS for the BSL and Rec periods, expressed as percentage of
recording time per 2 h. There were no significant genotype effects observed in these measures (PROC MIXED, P0.05).
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When the  power in NREMS of the first time point
of Rec sleep after SD was expressed as a percentage of
the  power during the time point preceding the SD,
the Per35/5 mice showed a trend for higher levels of 
power than the Per34/4 mice (198.1514.1 vs. 168.46
9.01%; PROC TTEST, P0.095).
Because  power during NREMS is an established
marker for sleep homeostasis regulation, we further
investigated the genotype effect on this parameter by
computing the time course of EEG  power during
NREMS (Fig. 6). In accordance with the data presented
in Fig. 6,  power was significantly higher in Per35/5
(compared to Per34/4) after SD, but only at the begin-
ning of the Rec-L period and during the Rec-D2 period
(PROC MIXED P0.05; for post hoc contrasts; see Fig. 6,
top panel), suggesting a more delayed Rec period in
the Per35/5 mice. This increase in  power was not
accompanied by changes in the bihourly time course of
VSs (Fig. 6, bottom panels). Fragmentation of the VSs
was also analyzed, and no changes were found between
the Per35/5 and the Per34/4 mice (data not shown).
Thus, the Per35/5 mice exhibited 1 of the 3 hallmarks of
high NREMS drive: an increase in SWE/ power, but
no increase in NREMS time or consolidation.
Gene expression in the cortex and hypothalamus
after SD
In the cortex, 816 transcripts showed significant differ-
ential expression between the Per35/5 and Per34/4 mice:
4268 between the Per35/5 and WT and 5131 between
the Per34/4 and WT [Table 2 and Ancillary Data (gene
expression data at http://sleep-sysbio.fhms.surrey.ac.
uk/Hasan_14/)]. A similar number of differentially ex-
pressed transcripts was observed in the hypothalamus
(Table 2 and Ancillary Data). When gene expression
between genotypes in both tissues was compared, there
were consistently more up-regulated transcripts than
down-regulated ones (Table 2 and Fig. 7A).
There were no differences between the Per35/5 and
the Per34/4 mice in the levels of expression in any of the
circadian clock genes in either tissue. However, when
KI and WT mice were compared, there were differences
in the expression of clock genes (Supplemental Table
S1). Clock was down-regulated in Per34/4 compared to
WT in both tissues. Nr1d1 was up-regulated in both KI
genotypes compared to WT in the hypothalamus. Per1
and Rora were up-regulated in Per35/5 compared with
WT mice in the cortex. Per3, Cry2, Csnk1d, and Bhlhe41
(Dec2) were all up-regulated, and Nr1d2 and Cry1 were
both down-regulated in both KI genotypes compared
with their WT expression in both tissues (Fig. 7B).
Thus, whereas there were no differences in clock gene
expression between the KI mice, the presence of the
VNTR did affect the expression of some clock genes
compared with that in the WT mice.
To investigate sets of significantly differentially
expressed genes that could be related to sleep regu-
lation, we ranked differentially expressed transcripts
according to their absolute fold change difference
between all 3 genotypes in the 2 tissues and analyzed
the top 200 transcripts (Ancillary Data). Some sleep-
related transcripts were differentially expressed in
the Per35/5 compared to Per34/4 tissues. These in-
cluded Nfkb1 (up-regulated in both tissues); Ifi47
(down-regulated in both tissues); Kcna2, Cacna2d2,
and Cacnb2 (up-regulated in the hypothalamus);
Slc29a3, Il1rl2, Tgfbi, Adh1, and Ptgis (down-regulated
in the hypothalamus); and Nkapl, Map4k5, Crhbp,
Trpc2, and Ilf3 (up-regulated in the cortex). Of
interest, Adora1 was up-regulated in the Per34/4 mice
compared to the WT in both tissues. In the Per35/5
mice, Adora1 did not appear in the top 200 fold-
change lists, but it was also significantly up-regulated
compared to WT in both tissues (Fig. 7B).
In addition to the sleep-related genes that ap-
peared in the top-ranked fold-change lists, we also
found significant differential expression for several
transcripts of the brain-specific marker for sleep
homeostasis Homer1. Two probes on the microarray
targeted the 5 prime untranslated region (5= UTR) of
8 mouse Homer1 transcripts (4 full-length transcripts
and 4 shorter transcripts), and they were up-regu-
lated in the KI mice compared to the WT in both
tissues and significantly more so in the Per35/5 com-
pared to the Per34/4 hypothalamus. Two other probes
targeted the 3= UTR of Homer1 (3 full-length tran-
scripts and 1 short one), and they were down-
regulated in both the KI groups, compared with the
WT mice in both tissues (Fig. 7C).
GO analysis of the transcripts differentially expressed
between the Per34/4 and Per35/5 mice produced almost
identical results for both tissues (Tables 3 and 4). The
top 10 biological processes and molecular functions
associated with the differential transcripts included the
metabolic process, the macromolecule metabolic pro-
cess, nucleotide binding, and heterocyclic compound
TABLE 2. Differentially expressed transcripts between genotypes after 12 h SD
Genotypes
Cortex Hypothalamus
DETs UR DR DETs UR DR
Per35/5 vs. Per35/5 816 492 324 716 398 318
Per35/5 vs. WT 4268 2806 1462 4823 2676 2147
Per35/5 vs. WT 5131 3213 1918 4138 2286 1852
KI vs. WT 3560 2297 1263 3579 1970 1609
DET, differentially expressed transcript; UR, up-regulated; DR, down-regulated.
9MOUSE MODELS FOR HUMAN Per3 SLEEP PHENOTYPES
binding. GO analysis of the 1647 transcripts that were
differentially regulated in both tissues in both the
Per34/4 and Per35/5 compared to the WT mice in both
tissues revealed similar differential expression associ-
ated with similar processes and functions (Table 5).
However, the same analysis also revealed subtle differ-
ences between the tissues: the nitrogen compound
metabolic process, the cellular nitrogen metabolic pro-
cess, metal ion binding, and cation binding were en-
riched only in the hypothalamus, whereas cellular
component organization or biogenesis, cellular protein
metabolic process, nucleoside phosphate binding, and
purine ribonucleoside triphosphate binding were en-
riched only in the cortex. When the gene expression
lists for both tissues were combined, differentially ex-
pressed genes between the Per34/4 and Per35/5 mice
were now associated with additional processes and
functions that included metabolism and modification
focused more on proteins (Table 5).
Gene expression in the hypothalamus during
behavioral suppression by light
Behavioral suppression by light in the ultradian
protocol was not significantly different between any
of the genotypes (data not shown). Fold changes in
hypothalamic gene expression between the KI and
WT mice exhibited normal distributions (Supple-
mental Fig. S1A). From these distributions, 282
probes were differentially expressed between the
Per35/5 and WT mice, and 96 probes were differen-
tially expressed between the Per34/4 and WT mice
(Supplemental Fig. S1A, see Supplemental Table S2
for top 30-fold change probes for each genotype).
This analysis showed that none of the core set of
circadian clock gene transcripts was differentially
expressed between the WT and KI tissues (Supple-
mental Fig. S1B). By contrast, among the probes that
were differentially expressed were genes of interest
for sleep homeostasis, including Homer1, Ptgs2, and
Tnfrsf25 (all down-regulated in the Per35/5 compared
to the WT tissues); Kcne2 (down-regulated in Per35/5
and up-regulated in Per34/4); and Prl (down-regu-
lated in Per34/4 and up-regulated in Per35/5). A
further 7 genes (Ccl21a, Slx1b, Rpp40, Ttr, Tmem72,
Sln, and Apoc4) were differentially expressed in both
the Per34/4 and Per35/5 tissues. Ccl21a (a chemokine
ligand) was down-regulated in tissues of both the KI
groups and was the most down-regulated probe in
the Per34/4 tissue. Gene enrichment and functional
Figure 7. Hypothalamic and cortical gene expression after SD in Per34/4 and Per35/5 mice. A) Distributions (number of probes)
of normalized fold change (log2) in expression of all detected hypothalamic (gray curve) and cortical (black dashed curve)
probes between Per34/4 and Per35/5. Percentages of detected probes that showed significant differential expression are also
indicated on the right y axis (gray bars, hypothalamus; black bars, cortex). B) Horizontal bars indicate up- and down-regulated
fold changes (black, down-regulated in Per35/5 vs. Per34/4; white, up-regulated in Per35/5 vs. Per34/4) in the differential
expression of a core set of circadian clock genes (top) and a selection of genes associated with sleep regulation (bottom) in both
tissues. Vertical dashed gray lines indicate maximum fold change observed in the clock gene transcripts, all nonsignificant (A,
B). C) Mean normalized expression in WT (gray), Per34/4 (black), and Per35/5 (white) of 2 Homer1 probes that target the 5= UTR
(left) and 2 probes that target the 3= UTR (right), averaged across both tissues. Error bars  sem.
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annotation analysis revealed that the 282 differen-
tially expressed probes in the Per35/5 hypothalamic
tissue were significantly associated with biological
processes and molecular functions that included
terms linked with neuronal development and signal-
ing, as well as the regulation of transcription (Sup-
plemental Fig. S1C). There were no significant GO
terms associated with the differentially expressed
probes in the Per34/4 mice, because of the smaller
number of probes analyzed.
TABLE 3. GO terms associated with genes differentially regulated between Per34/4 and Per35/5 in
the hypothalamus
GO term
Genes
observed
Genes in
category
Enrichment
ratio Adjusted P
Biological process
Metabolic 278 9,069 1.42 1.20E-10
Primary metabolic 241 7,662 1.46 1.30E-09
Cellular metabolic 238 7,571 1.46 1.52E-09
Organic substance metabolic 249 8,093 1.43 2.39E-09
Single-organism metabolic 253 8,434 1.39 1.99E-08
Cellular 356 13,317 1.24 6.37E-08
Macromolecule metabolic 195 6,456 1.40 1.05E-05
Cellular biosynthetic 137 4,141 1.54 1.71E-05
Organic substance biosynthetic 139 4,245 1.52 2.19E-05
Cellular macromolecule metabolic 174 5,669 1.42 2.23E-05
Molecular function
Binding 327 10,881 1.41 1.91E-15
Protein binding 194 6,206 1.46 1.65E-07
Catalytic activity 164 5,115 1.50 6.64E-07
Ion binding 167 5,230 1.50 6.64E-07
Organic cyclic compound binding 145 4,641 1.46 2.68E-05
Heterocyclic compound binding 144 4,592 1.47 2.68E-05
Nucleotide binding 82 2,268 1.69 6.74E-05
Nucleoside phosphate binding 82 2,268 1.69 6.74E-05
Metal ion binding 112 3,443 1.52 8.71E-05
Small-molecule binding 86 2,445 1.65 8.71E-05
TABLE 4. GO terms associated with genes differentially regulated between Per34/4 and Per35/5 in
the cortex
GO term
Genes
observed
Genes in
category
Enrichment
ratio Adjusted P
Biological process
Metabolic 333 9,069 1.53 9.72E-20
Cellular metabolic 291 7,571 1.60 7.60E-19
Organic substance metabolic 304 8,093 1.56 9.12E-19
Single-organism metabolic 310 8,434 1.53 6.60E-18
Primary metabolic 289 7,662 1.57 1.08E-17
Cellular macromolecule metabolic 231 5,669 1.70 1.40E-16
Macromolecule metabolic 248 6,456 1.60 5.54E-15
Organic cyclic compound metabolic 194 4,672 1.73 6.72E-14
Heterocycle metabolic 186 4,500 1.72 5.68E-13
Cellular aromatic compound metabolism 186 4,521 1.71 8.15E-13
Molecular function
Binding 379 10,881 1.44 8.20E-21
Organic cyclic compound binding 200 4,641 1.78 2.71E-16
Heterocyclic compound binding 199 4,592 1.79 2.71E-16
Small-molecule binding 122 2,445 2.06 3.95E-13
Nucleotide binding 114 2,268 2.08 1.64E-12
Nucleoside phosphate binding 114 2,268 2.08 1.64E-12
Ion binding 201 5,230 1.59 2.04E-11
Anion binding 105 2,264 1.92 2.21E-09
RNA binding 50 781 2.65 2.01E-08
Purine nucleoside binding 84 1,740 2.00 3.41E-08
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DISCUSSION
Our data show that expression of the primate-specific 4-
or 5-repeat PER3 VNTR polymorphism in mice altered
the time course of two established EEG markers of
sleep homeostasis:  activity during wakefulness and 
power during NREMS. By contrast, no genotype differ-
ences were observed between the KI mice in measures
of circadian period and responses to light or in the
expression levels of transcripts of the core set of circa-
dian clock genes. Moreover, insertion of the VNTR
associates with differential expression of genes linked
with sleep regulatory processes, including an estab-
lished marker of sleep homeostasis, Homer1.
The current mouse data showing that the number of
tandem repeats does not change circadian periodicity is
in line with previous mouse data showing no major
effect of Per3 KO (11, 13) and with human data showing
that the PER3 VNTR affects neither the in vitro nor in
vivo period when assessed in dim light (27). Also,
extensive whole-genome microarray analyses showed
no difference between hypothalamic and cortical ex-
pression of circadian clock genes between the two KI
genotypes after SD and also during an ultradian LD
protocol, whereas we observed significant differences in
the expression of genes associated with sleep. These
included Homer1 and Ptgs2 (39), Prl (40), Kcna2 (41),
and Adh1 (42, 43), whereas Adora1 (44) was up-regu-
lated in both the hypothalamic and cortical tissues in
the 2 KI groups compared with the WT.
In response to SD, GO analysis of differential gene
expression identified processes and functions that are
typically affected by sleep loss, such as macromolecular
metabolic processes. During the ultradian protocol,
where there was no behavioral phenotype, genes differ-
entially expressed between the Per35/5 and WT mice in
the hypothalamus were associated with GO terms that
included neuronal development and signaling. The
latter finding is of interest because of the individual
differences in cognitive performance and brain func-
tion that are associated with the human PER3 VNTR
(22–24). Therefore, taken together, these humanized
mouse data are consistent with existing human data
that suggest that the PER3 VNTR does not affect the
circadian clock in the hypothalamus, but is associated with
differences in homeostatic sleep regulation and cognitive
vulnerability to sleep loss and in mice with the differential
expression of transcripts that regulate and respond to
sleep and neuronal development and function.
Homer1a has been described as a brain-specific marker
of sleep homeostasis because its expression increases in
response to SD (39). In the current study, Homer1 expres-
sion was increased in the two KI genotypes compared with
the WT, more so in the Per35/5 mice in both tissues in the
SD and ultradian protocols. However, this was true only of
probes that targeted the 5= UTR of Homer1 transcripts;
probes that targeted the 3= UTR showed down-regulation
compared to the WT in both the KI genotypes. This result
suggests that there is up-regulated expression of nascent
mRNA for Homer1 in response to SD but reduced levels of
alternatively spliced transcripts.
As far as we are aware, this is the first time that a
common human polymorphism involved in sleep ho-
meostasis has been inserted into an animal model. A
rare familial single-nucleotide mutation in DEC2 regu-
lates sleep duration in humans, and insertion of this
mutation in mice also affects sleep duration in an
TABLE 5. GO terms associated with genes differentially regulated between Per34/4 and Per35/5 in
both the hypothalamus and cortex
GO term
Probes
observed
Enrichment
score
Percentage of
category Adjusted P
Biological process
Cellular protein modification process 21 2.89 25.93 1.10E-03
Protein modification process 21 2.89 25.93 1.10E-03
Macromolecule modification 22 2.92 27.16 1.10E-03
Cellular protein metabolic process 23 2.4 28.40 4.20E-03
Protein metabolic process 26 2.24 32.10 4.20E-03
Phosphatidylinositol phosphorylation 3 29.6 3.70 7.40E-03
Metabolic process 46 1.55 56.79 7.40E-03
Phosphorylation 14 2.95 17.28 1.16E-02
Lipid phosphorylation 3 25.49 3.70 1.16E-02
Primary metabolic process 40 1.6 49.38 1.56E-02
Molecular function
Small molecule binding 18 2.26 22.22 1.79E-02
Nucleotide binding 17 2.31 20.99 1.79E-02
Anion binding 17 2.31 20.99 1.79E-02
Nucleoside phosphate binding 17 2.31 20.99 1.79E-02
Binding 50 1.41 61.73 1.79E-02
Glycoprotein binding 3 13.18 3.70 1.99E-02
Purine nucleotide binding 14 2.43 17.28 1.99E-02
Ribonucleotide binding 14 2.42 17.28 1.99E-02
Purine nucleotide binding 14 2.44 17.28 1.99E-02
Purine nucleoside binding 13 2.3 16.05 2.44E-02
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SD-dependent way (45). The mutation that is linked
with familial advanced sleep phase disorder (FASPD)
has been reproduced in transgenic mice, but only with
regard to circadian phenotype; the effects on sleep
EEG were not assessed (46). An intronic SNP in the
potassium channel gene ABCC9 was found to be asso-
ciated with short periods of sleep in humans, and
silencing of the homologue gene in Drosophila created a
sleepless phenotype in the first part of the night (47).
However, although that study clearly suggests a role for
ABCC9 in sleep regulation, it did not identify the
causative genetic marker.
The lack of an effect of genotype on BSL VSs in the
current study contrasts with some previous studies in
clock gene transgenic mice. For example, Clock-mutant
mice showed a reduced BSL sleep duration (48),
Npas2-KO mice had reduced spindle frequency activity
in NREMS (49), and Cry1/Cry2 double-KO mice had
increased NREMS bout length and NREM  power (8).
It should be noted that, in the current study, Cry1
expression was highly down-regulated in the KI mice
compared with WT mice in both the hypothalamus and
cortex after SD. Overall, this observation implies that
the VNTR-mediated effects on sleep are observed only
when sleep is manipulated.
The higher EEG  activity in wakefulness observed in
the Per35/5 mice during forced wakefulness and the
genotype difference in BSL  power during REMS
observed in the Per35/5 mice are in line with the higher
/alpha power seen in PER35/5 humans, at BSL and
during SD (21).
The observation that during sleep Rec, the NREM 
power was higher in the Per35/5 mice is also consistent
with human data from PER35/5 individuals (21). In addi-
tion, the Per35/5 mice had a greater and more complete
(i.e., return to BSL level) sleep homeostatic response, as
quantified by the accumulation of NREM  power, when
compared to the Per34/4 mice. In addition, in a previous
human protocol of sleep restriction/deprivation, NREM 
power was found to be higher in the PER35/5 genotype
compared to the PER34/4 (22). These consistent observa-
tions between species are remarkable, given that the only
difference between these genotypes is the presence of
either the 4- or 5-repeat VNTR alleles.
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